Bendamustine and lenalidomide in relapsed/refractory lymphoid malignancies.
B. D. Cheson
Consultant or Advisory Role - Celgene; Cephalon
Research Funding - Celgene; Cephalon
C. S. Ujjani
No relevant relationships to disclose
S. M. Karim
No relevant relationships to disclose
T. Goswami
No relevant relationships to disclose
J. Crawford
No relevant relationships to disclose
E. A. Gehan
No relevant relationships to disclose